Cantor Fitzgerald’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-495,000
Closed -$4.97M 764
2022
Q4
$4.97M Buy
+495,000
New +$4.91M 0.11% 243

Other funds holding AONC

Cantor Fitzgerald's AONC Position: Q1 2023 in Review

Cantor Fitzgerald sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q1 2023, closing a stake of 495,000 shares — an estimated $4.97M sold.

Cantor Fitzgerald first reported a position in AONC in Q4 2022 and held it in 1 quarter. The position peaked at $4.97M in Q4 2022. 13 funds tracked by Wall St. Rank hold AONC as of Q1 2023.

  • Cantor Fitzgerald reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Cantor Fitzgerald sold 495,000 American Oncology Network, Inc. Class A Common Stock shares in Q1 2023, an estimated $4.97M.
  • Cantor Fitzgerald first reported a position in American Oncology Network, Inc. Class A Common Stock in Q4 2022 and held it in 1 quarter.
  • Cantor Fitzgerald's American Oncology Network, Inc. Class A Common Stock position peaked at $4.97M in Q4 2022.
  • 13 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q1 2023.

Based on Cantor Fitzgerald's 13F filing for Q1 2023, filed 15 May 2023.